Press releases

Boston Scientific Corporation (NYSE: BSX) today announced that the Court of Appeals for the Federal Circuit affirmed a District Court ruling which...

Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Cardiac Surgery and Vascular Surgery businesses to...

Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of the controlling interests in its auditory business and...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming JP Morgan Health Care Conference, in San Francisco. Paul...

Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval for its LIVIAN™ cardiac resynchronization therapy defibrillator...

Boston Scientific Corporation (NYSE: BSX) announced today that its TAXUS® Liberte™ paclitaxel-eluting coronary stent system has received...

Boston Scientific Corporation (NYSE: BSX) and Avista Capital Partners, a leading private equity firm, today jointly announced the...

Boston Scientific Corporation (NYSE: BSX) today welcomed the recommendation of a U.S. Food and Drug Administration (FDA) advisory panel to approve...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the BMO Capital Markets Healthcare Conference, which is being held...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, which is being held November 27...

Boston Scientific Corporation (NYSE: BSX) today announced that an amended agreement has been reached to settle claims associated with a series of...

Boston Scientific Corporation (NYSE: BSX) and GE Healthcare (NYSE: GE) today announced the industry's first patient data...

Boston Scientific Corporation (NYSE: BSX) today announced the signing of a definitive agreement for the sale of its Cardiac Surgery and Vascular...

Boston Scientific Corporation (NYSE: BSX) announced today that a jury in U.S. District Court in San Francisco has found that Boston Scientific...

Boston Scientific today announced that Keith Dawkins, M.D., and Takahiro Uchida, M.D., will be joining the Company's Clinical Sciences...

Boston Scientific Corporation (NYSE: BSX) today announced positive three-year results from its CABERNET and BEACH carotid artery...

Boston Scientific Corporation (NYSE: BSX) today announced five-year and final follow- up data from its TAXUS IV clinical trial. The...

Boston Scientific Corporation (NYSE: BSX) today announced nine-month data from the pivotal TAXUS ATLAS Small Vessel and Long Lesion...

Boston Scientific Corporation (NYSE: BSX) today welcomed results from the SPIRIT III Clinical Trial, which continue to support the...

Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of nearly 7,000 patients from its TAXUS ARRIVE 1...

Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2007, as well as guidance for...

Boston Scientific Corporation (NYSE: BSX) today announced several new initiatives designed to enhance short- and long-term shareholder value,...

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular...

Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its CONFIENT™ implantable cardioverter defibrillator (ICD). This...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30,...

Boston Scientific Corporation (NYSE: BSX) today released data reflecting experience from the first 15,000 patients(1) monitored wirelessly on the...

Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Ray Elliott as a Director. Mr. Elliott,...

Boston Scientific Corporation (NYSE: BSX) today announced results from the TAXUS WOMAN study, a gender specific analysis of the...

Boston Scientific Corporation (NYSE: BSX) today announced five-year and final results from its TAXUS II clinical trial,...

Boston Scientific Corporation (NYSE: BSX) today announced one-year results from the European and Intercontinental launch phases...

Boston Scientific Corporation (NYSE: BSX) today announced that three of its subsidiaries, Guidant Corporation, Cardiac Pacemakers Inc. and Guidant...

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the European...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bear Stearns 20th Annual Healthcare Conference, which is being held...

Boston Scientific Corporation (NYSE: BSX) today announced that it has successfully amended its $2 billion revolving line of credit and $5 billion...

Boston Scientific Corporation (NYSE: BSX) today announced its intention to explore the sale of its Cardiac Surgery and Vascular Surgery businesses...

Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into an agreement to amend its merger agreement with Advanced Bionics,...

Boston Scientific Corporation (NYSE: BSX) today provided an update on its plans to strengthen operating and financial performance as part of its...

Boston Scientific Corporation (NYSE: BSX) today announced its intention to explore the sale of its fluid management business as part of the...

Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2007, as well as guidance for net...

Boston Scientific Corporation (NYSE: BSX) today announced the beginning of clinical trial enrollment in studies evaluating its third-generation...

Boston Scientific Corporation (NYSE: BSX) today announced the successful implantation of the Company's TAXUS® Petal™ Bifurcation...

Boston Scientific Corporation (NYSE: BSX) today announced that an agreement has been reached to settle claims associated with a series of product...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2007...

Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Precision Plus™ Spinal Cord Stimulation (SCS) System, the world's...

Boston Scientific Corporation (NYSE: BSX) today announced it has signed a definitive agreement to acquire Remon Medical Technologies Inc., a...

Boston Scientific Corporation (NYSE: BSX) today announced that it has purchased technology for treating symptomatic benign prostatic hyperplasia...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 28th Annual Healthcare Conference, which is being held June...

Boston Scientific Corporation (NYSE: BSX) today welcomed the publication of an article in the Journal of American College of Cardiology (JACC)...

Boston Scientific Corporation (NYSE: BSX) today announced enrollment of the first patient in the SONOMA post-market approval study of the Company's...

Boston Scientific Corporation (NYSE: BSX) today announced that it has received CE Mark for its TAXUS® Liberte™ Long...